Balyasny Asset Management L.P.

Position in FLGT — Fulgent Genetics, Inc.

CIK 1218710 Chicago, IL

Position in FLGT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,130,199

+$810,191 QoQ

Shares Held

55,078

+242.2% QoQ

Ownership

0.200%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#46

of 142 holders

Holding Since

Sep 2021

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Balyasny Asset Management L.P. holds $727,123,354 across 18 Diagnostics & Research names. FLGT ranks #11 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	449,628	$225,425,494
2	DHR	Danaher Corp /De/	759,207	$144,613,749
3	IQV	Iqvia Holdings Inc.	700,425	$135,336,117
4	MTD	Mettler Toledo International Inc/	54,686	$69,861,911
5	DGX	Quest Diagnostics Inc	275,371	$58,364,883
6	WAT	Waters Corp /De/	138,443	$51,921,662
7	GH	Guardant Health, Inc.	124,368	$18,658,930
8	RVTY	Revvity, Inc.	63,056	$7,015,610

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,130,199	55,078	+242.2%	Shares	Sole	2026-08-14
2025-06-30	$320,008	16,097	-76.8%	Shares	Sole	2025-08-14
2025-03-31	$1,173,299	69,426	+163.8%	Shares	Sole	2025-05-15
2024-12-31	$486,001	26,313	+139.3%	Shares	Sole	2025-02-14
2024-03-31	$238,569	10,994	+27.7%	Shares	Sole	2024-05-13
2023-06-30	$318,791	8,609	-37.2%	Shares	Sole	2023-08-14
2022-12-31	$407,986	13,700	-59.7%	Shares	Sole	2023-02-14
2022-09-30	$1,297,337	34,033	+4.1%	Shares	Sole	2022-11-15
2022-06-30	$1,783,240	32,702	+1004.1%	Shares	Sole	2022-08-15
2021-09-30	$266,431	2,962	—	Shares	Sole	2021-12-01
No filing history on record for this holder in this stock.